Black Swift Group LLC Acquires 508 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Black Swift Group LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 11.0% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,108 shares of the medical equipment provider's stock after purchasing an additional 508 shares during the quarter. Black Swift Group LLC's holdings in Intuitive Surgical were worth $2,530,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Norges Bank bought a new stake in shares of Intuitive Surgical in the 4th quarter worth $2,401,493,000. GAMMA Investing LLC boosted its position in Intuitive Surgical by 54,010.7% during the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after purchasing an additional 3,022,979 shares during the last quarter. Capital Research Global Investors lifted its position in shares of Intuitive Surgical by 25.5% in the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock worth $1,764,904,000 after buying an additional 687,906 shares during the last quarter. Northern Trust Corp lifted its position in shares of Intuitive Surgical by 15.8% in the fourth quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock worth $1,889,126,000 after buying an additional 494,496 shares during the last quarter. Finally, GQG Partners LLC lifted its position in shares of Intuitive Surgical by 42.5% during the 4th quarter. GQG Partners LLC now owns 1,145,300 shares of the medical equipment provider's stock worth $597,801,000 after purchasing an additional 341,812 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,500 shares of the firm's stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares of the company's stock, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the transaction, the director directly owned 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 7,798 shares of company stock worth $3,955,331 in the last quarter. 0.70% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on ISRG shares. Wells Fargo & Company boosted their price target on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a research note on Wednesday. Barclays reduced their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Wall Street Zen raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday. Evercore ISI increased their target price on Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a report on Tuesday, July 8th. Finally, UBS Group raised their price objective on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a research report on Wednesday. One analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $592.05.

Intuitive Surgical Price Performance

Shares of ISRG stock traded up $7.25 on Friday, reaching $495.86. 1,870,941 shares of the company were exchanged, compared to its average volume of 1,842,693. The company has a market cap of $177.73 billion, a price-to-earnings ratio of 69.16, a PEG ratio of 5.45 and a beta of 1.64. The company has a 50-day moving average of $529.86 and a 200-day moving average of $535.13. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business's revenue was up 21.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.78 EPS. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.